Zinc transporter 8 autoantibody testing requires age-related cut-offs

INTRODUCTION: Zinc transporter 8 autoantibodies (ZnT8A) are biomarkers of beta cell autoimmunity in type 1 diabetes that have become more widely available to clinicians in recent years. Robust control population-defined thresholds are essential to ensure high clinical specificity in islet autoantibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Grace, Sian Louise, Cooper, Angela, Jones, Angus G, McDonald, Timothy James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340275/
https://www.ncbi.nlm.nih.gov/pubmed/34348918
http://dx.doi.org/10.1136/bmjdrc-2021-002296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340275/
https://www.ncbi.nlm.nih.gov/pubmed/34348918
http://dx.doi.org/10.1136/bmjdrc-2021-002296

Ejemplares similares